American Oriental Bioengineering, Inc.
AOBI · OTC
9/30/2013 | 6/30/2013 | 3/31/2013 | 12/31/2012 | |
|---|---|---|---|---|
| Revenue | $18 | $20 | $21 | $62 |
| % Growth | -11.3% | -3.7% | -66.3% | – |
| Cost of Goods Sold | $15 | $15 | $17 | $35 |
| Gross Profit | $3 | $5 | $5 | $27 |
| % Margin | 17.3% | 24.7% | 21.4% | 43.3% |
| R&D Expenses | $3 | $2 | $1 | $1 |
| G&A Expenses | $9 | $11 | $12 | $14 |
| SG&A Expenses | $15 | $14 | $16 | $19 |
| Sales & Mktg Exp. | $5 | $3 | $0 | $6 |
| Other Operating Expenses | $4 | -$0 | $6 | $5 |
| Operating Expenses | $22 | $15 | $21 | $25 |
| Operating Income | -$19 | -$10 | -$19 | -$30 |
| % Margin | -105.8% | -51% | -90.5% | -47.8% |
| Other Income/Exp. Net | -$2 | -$2 | -$4 | -$36 |
| Pre-Tax Income | -$21 | -$12 | -$21 | -$35 |
| Tax Expense | $0 | $1 | $0 | $1 |
| Net Income | -$21 | -$13 | -$21 | -$36 |
| % Margin | -118.1% | -63.5% | -100.5% | -57.5% |
| EPS | -290.36 | -176.28 | -288.69 | -485.66 |
| % Growth | -64.7% | 38.9% | 40.6% | – |
| EPS Diluted | -290.36 | -176.28 | -288.69 | -485.66 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $3 | $3 | $3 | $3 |
| EBITDA | -$16 | -$7 | -$17 | -$31 |
| % Margin | -89.3% | -35.8% | -80.8% | -50% |